Recent Headlines
Within Pharmaceuticals
Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over... - April 18, 2024 - Mirror Biologics, Inc.
Announcing the Launch of the HumaSpan Longevity Supplements Website
HumaSpan Offers a Variety of High Quality Longevity Supplements - April 16, 2024 - HumaSpan
The °C Rail with Slidable Sensors is the Latest Addition to the Degree Controls Platform of Multipoint Airflow Instrumentation
The all-new °C Rail multipoint airflow instrumentation system from Degree Controls is designed with a versatile array of slidable sensors to accommodate changing test setups. - April 15, 2024 - Degree Controls
Nadrich Accident Injury Lawyers Opens New Tulare, CA Office
Nadrich Accident Injury Lawyers, a California personal injury law firm, is proud to announce the opening of its new office in Tulare, CA. - April 13, 2024 - Nadrich & Cohen, LLP
I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression
I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.
Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management
Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Minus K Congratulates to the Winners of Their 2023/2024 Educational Giveaway
Minus K congratulates the four winners of the Minus K's 2023/2024 Educational Giveaway. Over $75,000 of new passive mechanical hub hertz vibration isolators have been granted to universities and colleges in the U.S. over the last ten years. - April 10, 2024 - Minus K Technology Inc.
FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity
FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics
Renowned Advocate Lorrinda Gray-Davis to Speak at TRIO's Remember & Rejoice Event
As a guest speaker, Lorrinda Gray-Davis will share her personal journey of hope, resilience, and gratitude, highlighting the profound impact of organ donation on individuals, families, and communities. "Remember & Rejoice" stands as the single largest gathering of donor families and transplant recipients in the country, providing a sacred space for reflection, remembrance, and rejoicing. - April 06, 2024 - TRIO-Oklahoma
Lola Snacks Introduces Revolutionary Gut Health Product on WeFunder Platform with $100K Already Raised
We are thrilled to announce Lola Snacks' launch on WeFunder with $100K already raised. We're on a mission to redefine gut health. Join us in empowering wellness and sustainability. - April 04, 2024 - Lola Snacks
Evolution Analytics Recognized by CIO Bulletin in Their "30 Leading Companies to Watch" Compilation for 2024
Elevating Data Expertise: Evolution Analytics' Journey to Becoming a Top Contender in Data and AI Innovation for 2024 - April 04, 2024 - Evolution Analytics
Geoprise Releases Software to Support New SEC Climate Disclosure Rules
New release to substantially reduce the cost of compliance for most companies. - April 04, 2024 - Geoprise Technologies Corporation
Portable Soft-Serve Ice Cream Cart for Indoor Stadiums and Venues
Sports fans, concert goers and conference attendees can now enjoy Mister Softee soft serve ice cream from a new battery operated push cart. - April 02, 2024 - Exergy Energy
Homeopathic.AI Launches AI-Powered Homeopathy Assistant
Homeopathic.AI, an innovative tech startup, is thrilled to unveil the launch of the AI assistant focused on homeopathic medicine. This revolutionary AI tool aims to offer users bespoke, easily accessible, and precise guidance on homeopathic health care. - April 02, 2024 - Homeopathic AI Inc.
Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare
New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.
Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology
The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innovative Navacim™ regulatory T cells (Treg) immune tolerization platform technology to develop therapies for Inflammatory Bowel Disease Parvus Therapeutics announced today that it has entered into an... - March 20, 2024 - Parvus Therapeutics U.S., Inc.
AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry
California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper
MENADNA and ProPhase Labs' (NASDAQ: PRPH) Wholly-Owned Subsidiary, Nebula Genomics, Announce Strategic Partnership to Enhance Genomic Testing in Jordan, Oman and Iraq
MENADNA Inc., has entered into an exclusive partnership with ProPhase Labs' subsidiary, Nebula Genomics, aiming to advance genomic testing in Jordan, Oman, and Iraq. This collaboration will leverage Nebula Genomics' advanced sequencing technologies and MENADNA's bioinformatics capabilities to improve the quality and relevance of genomic data in these historically underserved regions. - March 18, 2024 - MENADNA
Revolutionary Access to Dental Solutions: Digital Denture Studio Unveils NHS Discounts and Hassle-Free Process
Digital Denture Studio, a pioneering dental laboratory, is redefining access to dental solutions by introducing exclusive NHS discounts and a hassle-free process. This innovative approach aims to make high-quality dental care more accessible and affordable for all patients, revolutionizing the... - March 17, 2024 - Digital Denture Studio Ltd
ACL Digital and PhoenixAI.tech Partner to Take AI-Driven Drone Technology to New Heights
The strategic partnership enhances ACL Digital’s capabilities with PhoenixAI.tech, focusing on AI drone solutions for UAVs, IoT, and edge computing to revolutionize operations significantly Beyond Visual Line of Sight (BVLOS) missions. - March 16, 2024 - ACL Digital
Creative Biolabs: Illuminate Neurological Disease Research and Therapy Development with Customized Animal Models
Creative Biolabs is proud to announce its new-year resolution to dive deeper into sourcing professional animal model solutions for neurological disorder studies. - March 15, 2024 - Creative Biolabs
iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease
iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical... - March 11, 2024 - iView Therapeutics Inc.
Defined Bioscience Introduces Ready-CEPT™: A New Cell Viability Enhancer
Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery. - March 11, 2024 - Defined Bioscience Inc.
Utech Products Inc. Achieves ISO 9001
Utech Products Inc. Achieves ISO 9001 Certification (Certification Registration No. 961 24 5889), Demonstrating Commitment to Quality and Customer Satisfaction. - March 09, 2024 - Utech Products Inc.
Evolution Analytics Named Among Top 20 AI Solution Providers for 2024 by Enterprise Viewpoint
Evolution Analytics, a premier data and analytics consulting firm for mid-market organizations, has been recognized in Enterprise Viewpoint's Top 20 AI Solution Providers for 2024. This recognition highlights Evolution Analytics' strategic approach to leveraging AI through its EAAdvantage™ Analytics Framework, its alignment of technology adoption with business goals, and its growing influence across various sectors. - March 06, 2024 - Evolution Analytics
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
Creative Biolabs Supplies Recombinant Antibodies for Pharmaceutical Breakthroughs
Creative Biolabs reaffirmed its dedication to supplying high-quality antibody reagents in 2024. - February 28, 2024 - Creative Biolabs
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company
New LGBTQ+ Screenplay Wins Platinum in Film Festival
Long Island writer debuts emotional story based on true events shining much needed light on opioid crisis in queer community. "You Are What You Love," a sapphic drama about a young woman struggling with recovery from her opioid addiction while navigating love and loss, recently won Platinum in the LGBTQ Unbordered International Film Festival. The screenplay, based on true events, gives a realistic portrayal of the unique obstacles the LGBTQ+ community faces. - February 15, 2024 - You Are What You Love Movie
Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.
Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation
In a groundbreaking development, the College of Health Sciences at the University of Memphis, spearheaded by leading researchers Janine Hellenbrand, Richard J. Bloomer, and Marie Van der Merwe, has revealed the remarkable effects of NAD3® supplementation on adult stem cell circulation in... - February 14, 2024 - High Performance Nutrition
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC
New Audio Feature for the Popular GCP Training
Pharma Lessons has added voice over functionality to their popular International Good Clinical Practice training. The audio is beautifully matched with the content of the course and is created by a native US speaker who is also a professional e-learning narrator. The voiceover has been recorded... - February 11, 2024 - Pharma Lessons
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel MVT's cutting-edge technologies into the market. - February 10, 2024 - Microvascular Therapeutics, Inc.
expEDIum Announces Successful Partnership with Medical Billing Service & Long-Term Care Medical Group, Inc.
Expanding its footprint in the healthcare industry, expEDIum is excited to announce the successful collaboration with Long-Term Care Medical Group, Inc. The partnership, initiated in October 2022, has flourished into a dynamic relationship, with Ms. Balwinder Bains, owner of the Medical Billing... - February 08, 2024 - expEDIum
Flow Circuits and Rapid Fluidics Ltd. Announce Partnership to Drive Microfluidic Innovation
Flow Circuits design platform and Rapid Fluidics 3D Print capabilities perfectly complement each other for rapid fluidic system development. Combined they empower researchers in diverse markets such as Pharmaceutical & Life Sciences Research, Point of Care Testing and Clinical Diagnostics, and Environment and Industrial Analytics. - February 05, 2024 - Rapid Fluidics Ltd
Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston
AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration - February 04, 2024 - Cambridge Healthtech Institute
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Creative Diagnostics has announced its extensive portfolio of AAV Reagent Solutions to support researchers. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics is pleased to announce the launch of its Serum Plate Agglutination Test. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics has announced the launch of Aflatoxin Test Reagents to detect harmful mycotoxins in various food products. - February 04, 2024 - Creative Diagnostics
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, Inc.
George W. Denninghoff Appointed EVP, Americas at Simms & Associates
Simms & Associates proudly welcomes George W. Denninghoff as Executive Vice President, Americas. With 25+ years of success in driving revenues and fostering customer satisfaction, George aligns his expertise with the company's North American growth goals. CEO Amanda Simms sees his appointment as pivotal in advancing Simms & Associates' global leadership in workforce management. - January 26, 2024 - Simms & Associates
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research
Creative Diagnostics has announced P53 and TP53 antibodies and solutions to support cancer research. - January 26, 2024 - Creative Diagnostics
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group